Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.
about
Advances in targeted proteomics and applications to biomedical researchComplement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study.Early prediction of autoimmune (type 1) diabetes.Molecular signatures differentiate immune states in type 1 diabetic familiesInnate inflammation in type 1 diabetesCharacterization of the human aqueous humour proteome: A comparison of the genders.Possible type 1 diabetes risk prediction: Using ultrasound imaging to assess pancreas inflammation in the inducible autoimmune diabetes BBDR modelBlood-based signatures in type 1 diabetes.Proteome-wide alterations on adipose tissue from obese patients as age-, diabetes- and gender-specific hallmarksProinflammatory and lipid biomarkers mediate metabolically healthy obesity: A proteomics study.Type 1 diabetes cadaveric human pancreata exhibit a unique exocrine tissue proteomic profileIncreased complement activation in human type 1 diabetes pancreata.Identification of differentially expressed serum proteins in infectious purpura fulminans.Early signs of disease in type 1 diabetes.Temporal profiles of plasma proteome during childhood development.Understanding type 1 diabetes through proteomics.Peptide serum markers in islet autoantibody-positive children.Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.Temporal expression profiling of plasma proteins reveals oxidative stress in early stages of Type 1 Diabetes progression.Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteins.Early life origin of type 1 diabetes.The progress and potential of proteomic biomarkers for type 1 diabetes in children.A new method to evaluate the dose-effect relationship of a TCM formula Gegen Qinlian Decoction: "Focus" mode of integrated biomarkers.The 88-kDa Eales' protein in serum is a complex of haptoglobin, complement C3, and galectin-1 as identified by liquid chromatography coupled mass spectrometry.Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target
P2860
Q28066912-164480BA-7528-4FE7-923B-BDC1C4232B39Q28601170-C0BA5E7D-A202-4F03-A4DF-B12477CD79C3Q33854613-9265F977-DE32-4DFD-8C01-C920BB668F29Q34393367-0A23831A-D302-4896-BBCA-488CCBE6EFE0Q36225939-D9D3B737-5065-4289-BEF1-9B60F4FBCB98Q36300702-91C4BAC5-C075-4A46-8CE0-AFD05FA4FE2FQ36399376-E808BB8B-9306-4C24-A1BD-075F5FBF89DAQ36552481-B801F0D6-5787-4B12-9EB5-FF76FC6642F8Q36886235-032B7647-B3C2-428D-A258-41855B813B1BQ36940729-546F31FC-74C8-4B41-AACA-65CF31EAAB12Q36970856-E83E6518-06AC-4A16-8EAF-0AE536A4A162Q37278134-9FBC408A-9E26-4E5D-B69C-877ADA6BE294Q37603334-6D1DA282-ACEF-42FC-9C26-A96ADE2BCC91Q38895414-8114B40B-C9B0-431D-AC81-60F4B4AAA2D6Q39150450-0A88F760-3AAE-4601-AB6D-5657797603AEQ39398068-C95AE01F-8824-45A2-822C-0F02C348190FQ40488540-ABAD769C-0FC1-4BE5-9148-35DE64CF5C96Q41173805-E6731D57-BD58-45E3-9D2D-05A709AD95F0Q46290391-72031131-0214-496E-9C04-E2561CC56AB8Q47136739-7DFEB6CD-6002-4A9F-B7A2-9A197CAA0277Q48244211-824B3EC6-88A0-44CE-BA0F-121C7D01B0FEQ48720838-DC4BF4B0-9DD0-4292-9913-1E05F98545FEQ50672630-04E2A487-5212-4C51-AF40-443162543B14Q51394645-33CFF2A4-E115-4937-8A63-96A1FCA775FCQ58702505-5577C078-D341-4F23-A0A0-3A9B4A264EF7
P2860
Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.
@ast
Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.
@en
type
label
Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.
@ast
Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.
@en
prefLabel
Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.
@ast
Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.
@en
P2093
P2860
P50
P356
P1476
Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.
@en
P2093
Marina A Gritsenko
Mark A Atkinson
Patricia W Mueller
Therese R W Clauss
Thomas L Fillmore
P2860
P304
P356
10.1084/JEM.20111843
P407
P577
2012-12-31T00:00:00Z